HomeCompareAHPI vs JNJ

AHPI vs JNJ: Dividend Comparison 2026

AHPI yields 50000.00% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AHPI wins by $4.789070889867552e+23M in total portfolio value
10 years
AHPI
AHPI
● Live price
50000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.789070889867552e+23M
Annual income
$477,030,307,353,597,400,000,000,000,000.00
Full AHPI calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — AHPI vs JNJ

📍 AHPI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAHPIJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AHPI + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AHPI pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AHPI
Annual income on $10K today (after 15% tax)
$4,250,000.00/yr
After 10yr DRIP, annual income (after tax)
$405,475,761,250,557,800,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, AHPI beats the other by $405,475,761,250,557,800,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AHPI + JNJ for your $10,000?

AHPI: 50%JNJ: 50%
100% JNJ50/50100% AHPI
Portfolio after 10yr
$2.394535444933776e+23M
Annual income
$238,515,153,676,798,700,000,000,000,000.00/yr
Blended yield
99.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AHPI
No analyst data
Altman Z
-0.3
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AHPI buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAHPIJNJ
Forward yield50000.00%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$4.789070889867552e+23M$30.3K
Annual income after 10y$477,030,307,353,597,400,000,000,000,000.00$4,689.40
Total dividends collected$4.7878388715795706e+23M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AHPI vs JNJ ($10,000, DRIP)

YearAHPI PortfolioAHPI Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$5,010,700$5,000,000.00$10,592$272.30+$5.00MAHPI
2$2,346,810,047$2,341,448,598.13$11,289$357.73+$2346.80MAHPI
3$1,027,408,478,283$1,024,897,391,532.38$12,123$472.89+$1027408.47MAHPI
4$420,435,006,832,721$419,335,679,760,958.80$13,141$629.86+$420435006.82MAHPI
5$160,823,792,302,236,830$160,373,926,844,925,820.00$14,408$846.81+$160823792302.22MAHPI
6$57,504,652,079,586,796,000$57,332,570,621,823,390,000.00$16,021$1,151.60+$57504652079586.78MAHPI
7$19,220,418,850,978,506,000,000$19,158,888,873,253,350,000,000.00$18,122$1,588.22+$19220418850978508.00MAHPI
8$6,005,321,287,350,842,000,000,000$5,984,755,439,180,295,000,000,000.00$20,930$2,228.20+$6005321287350842368.00MAHPI
9$1,754,001,526,315,678,800,000,000,000$1,747,575,832,538,213,200,000,000,000.00$24,792$3,191.91+$1.7540015263156787e+21MAHPI
10$478,907,088,986,755,200,000,000,000,000$477,030,307,353,597,400,000,000,000,000.00$30,274$4,689.40+$4.789070889867552e+23MAHPI

AHPI vs JNJ: Complete Analysis 2026

AHPIStock

Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The company offers respiratory care/anesthesia products, including air compressors, calibration equipment, humidifiers, croup tents, and equipment dryers, as well as respiratory disposable products, such as oxygen tubing products, facemasks, cannulas, and ventilator circuits; and home respiratory care products comprising aluminum oxygen cylinders, oxygen regulators, pneumatic nebulizers, portable suction equipment, and a line of respiratory disposable products. It also provides medical gas equipment, which include construction products consisting of in-wall medical system components, central station pumps and compressors, and headwalls; regulation devices and suction equipment comprising flowmeters, vacuum regulators, and pressure regulators, as well as related adapters, fittings, and hoses that measure, regulate, monitor, and transfer medical gases from walled piping or equipment to patients; and disposable oxygen cylinders to provide oxygen for short periods. In addition, the company offers emergency medical products that include respiratory/resuscitation products, such as demand resuscitation valves, portable resuscitation systems, bag masks and related products, emergency transport ventilators, precision oxygen regulators, minilators, multilators, and humidifiers; and trauma and patient handling products that include spine immobilization products, pneumatic anti-shock garments, and trauma burn kits. It serves hospitals, hospital equipment dealers, hospital construction contractors, home health care dealers, emergency medical products dealers, and others. The company was incorporated in 1979 and is headquartered in St. Louis, Missouri.

Full AHPI Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this AHPI vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AHPI vs SCHDAHPI vs JEPIAHPI vs OAHPI vs KOAHPI vs MAINAHPI vs ABBVAHPI vs MRKAHPI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.